Cargando…

Alzheimer’s Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation

Early-onset Alzheimer’s disease (AD) is associated with variants in amyloid precursor protein (APP) and presenilin (PSEN) 1 and 2. It is increasingly recognized that patients with AD experience undiagnosed focal seizures. These AD patients with reported seizures may have worsened disease trajectory....

Descripción completa

Detalles Bibliográficos
Autores principales:	Lehmann, Leanne, Lo, Alexandria, Knox, Kevin M., Barker-Haliski, Melissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254705/ https://www.ncbi.nlm.nih.gov/pubmed/33929683 http://dx.doi.org/10.1007/s11064-021-03332-y

Ejemplares similares

Can Old Animals Reveal New Targets? The Aging and Degenerating Brain as a New Precision Medicine Opportunity for Epilepsy
por: del Pozo, Aaron, et al.
Publicado: (2022)

Loss of normal Alzheimer's disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure model
por: Lehmann, Leanne M., et al.
Publicado: (2023)

Diurnal burden of spontaneous seizures in early epileptogenesis in the post‐kainic acid rat model of epilepsy
por: Mizuno, Stephanie, et al.
Publicado: (2021)

The overlap between Alzheimer's disease and epilepsy uncovered by transcriptome sequencing
por: Jiang, Xiaowen, et al.
Publicado: (2020)

Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital
por: Barker‐Haliski, Melissa, et al.
Publicado: (2021)

Reductions in Hydrogen Sulfide and Changes in Mitochondrial Quality Control Proteins Are Evident in the Early Phases of the Corneally Kindled Mouse Model of Epilepsy
por: Cho, Christi, et al.
Publicado: (2022)

Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs
por: Svob Strac, Dubravka, et al.
Publicado: (2016)

Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease
por: Vande Vyver, Maxime, et al.
Publicado: (2022)

Toward refining Alzheimer's disease into overlapping subgroups
por: Hascup, Erin R., et al.
Publicado: (2020)

Frontline Sodium Channel-Blocking Antiseizure Medicine Use Promotes Future Onset of Drug-Resistant Chronic Seizures
por: Zierath, Dannielle, et al.
Publicado: (2023)

Neuronal death in Alzheimer’s disease and therapeutic opportunities
por: Donev, Rossen, et al.
Publicado: (2009)

A companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK3 Pharmacology Working Group of the ILAE/AES Joint Translational Task Force
por: Barker‐Haliski, Melissa, et al.
Publicado: (2018)

Necroptosis and Alzheimer’s Disease: Pathogenic Mechanisms and Therapeutic Opportunities
por: Zhang, Ruxin, et al.
Publicado: (2023)

Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities
por: Gao, Chao, et al.
Publicado: (2023)

Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
por: Patra, Pabitra Hriday, et al.
Publicado: (2018)

Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities
por: Cedazo-Mínguez, Angel
Publicado: (2007)

Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
por: Xu, Kexin, et al.
Publicado: (2021)

Clinical Spectrum and Trajectory of Innovative Therapeutic Interventions for Insomnia: A Perspective
por: Lo, Yun-Jo, et al.
Publicado: (2023)

Innovation in Brain Tumor Treatment: A Nurse Perspective
por: Reddelle, Alexandria K
Publicado: (2021)

Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease
por: Kline, Adam
Publicado: (2012)

The Role of the Transcription Factor Nrf2 in Alzheimer’s Disease: Therapeutic Opportunities
por: De Plano, Laura Maria, et al.
Publicado: (2023)

Neuroinflammation and progressive myoclonus epilepsies: from basic science to therapeutic opportunities
por: Sanz, Pascual, et al.
Publicado: (2020)

Neurodegeneration in Alzheimer’s disease and glaucoma: overlaps and missing links
por: Sen, Sagnik, et al.
Publicado: (2020)

Dissecting the limited genetic overlap of Parkinson's and Alzheimer's disease
por: Stolp Andersen, Maren, et al.
Publicado: (2022)

Syncope and Epilepsy coexist in ‘possible’ and ‘drug-resistant’ epilepsy (Overlap between Epilepsy and Syncope Study - OESYS)
por: Ungar, Andrea, et al.
Publicado: (2017)

Genetic Overlap Between Alzheimer’s Disease and Depression Mapped Onto the Brain
por: Monereo-Sánchez, Jennifer, et al.
Publicado: (2021)

Innovation in cancer therapeutics and regulatory perspectives
por: Sharma, Pinky, et al.
Publicado: (2022)

Alzheimer’s Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound
por: Baazaoui, Narjes, et al.
Publicado: (2022)

Histaminergic neurotransmission in aging and Alzheimer's disease: A review of therapeutic opportunities and gaps
por: Satpati, Abhijit, et al.
Publicado: (2023)

Epilepsy and Alzheimer’s Disease: Current Concepts and Treatment Perspective on Two Closely Related Pathologies
por: Leo, Antonio, et al.
Publicado: (2022)

Symptomatic, Genetic, and Mechanistic Overlaps between Autism and Alzheimer’s Disease
por: Nadeem, Muhammad Shahid, et al.
Publicado: (2021)

MRI and Clinical Biomarkers Overlap between Glaucoma and Alzheimer’s Disease
por: Martucci, Alessio, et al.
Publicado: (2023)

Genetic overlap between Alzheimer’s disease and Parkinson’s disease at the MAPT locus
por: Desikan, Rahul S., et al.
Publicado: (2015)

The overlap between vascular disease and Alzheimer’s disease - lessons from pathology
por: Attems, Johannes, et al.
Publicado: (2014)

Overlap between Central and Peripheral Transcriptomes in Parkinson’s Disease but Not Alzheimer’s Disease
por: Hooshmand, Kosar, et al.
Publicado: (2022)

Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes
por: Sochacki, Andrew L, et al.
Publicado: (2016)

Commonalities for comorbidity: Overlapping features of the endocannabinoid system in depression and epilepsy
por: Epps, S. Alisha
Publicado: (2022)

Perspective: Therapeutic Potential of Flavonoids as Alternative Medicines in Epilepsy
por: Kwon, Jae Young, et al.
Publicado: (2019)

Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer’s Disease: Present Status and Future Opportunities
por: Ovais, Muhammad, et al.
Publicado: (2018)

cAMP Compartmentalization in Cerebrovascular Endothelial Cells: New Therapeutic Opportunities in Alzheimer’s Disease
por: Viña, Dolores, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qtp4sckvc9nptq1bn9c79kns0n